Connect Sign In
Dan Albertson, MD, president of ARUP’s University Business Unit, aims to rely on his and his colleagues’ clinical practice and expertise to continuously improve care for patients at University of Utah Health and Huntsman Cancer Institute and to share the knowledge gained with hospitals and health…
FDA leaders answered questions on artificial intelligence (AI), international regulations, and representation in clinical trials during the Utah Life Sciences Summit.
ARUP has been awarded a CDC contract for avian influenza A (H5N1) test development, which recognizes our expertise and experience with assay development and our desire to serve public health needs.
The lone star tick, which can transmit infectious diseases and trigger a serious red meat allergy, is spreading into new areas. ARUP Consult offers guidance to help diagnose tickborne illnesses.
ARUP’s declaration amplifies the lawsuit’s claims that the FDA does not have legal authority over laboratory testing services and that regulating these services is unreasonable.
ARUP Laboratories is committed to helping clients and the clinical laboratory community navigate regulatory changes and is offering current resources and a new webinar.
“Not a lot of companies last 40 years. It’s worth marking the moment because ARUP is not just existing. We’re thriving,” said Andy Theurer, CEO. Throughout ARUP Laboratories’ 40 years, there have been many remarkable moments.
ARUP experts will discuss the challenges for labs, the complications for patients and providers, and key differences between the FDA’s proposed rule and the final rule.
From its inception in 1984 to the present day, ARUP has stood the test of time by staying true to a mission to put the patient first, blend business with academics and research, and focus on the future.
